{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:40:53Z","timestamp":1786995653245,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"University of Connecticut Academic Plan Grant"},{"name":"Colombian Department of Sciences and Technology"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.phrs.2016.03.006","type":"journal-article","created":{"date-parts":[[2016,3,11]],"date-time":"2016-03-11T13:00:58Z","timestamp":1457701258000},"page":"93-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Reduced in vivo toxicity of doxorubicin by encapsulation in cholesterol-containing self-assembled nanoparticles"],"prefix":"10.1016","volume":"107","author":[{"given":"Laura","family":"Gonzalez-Fajardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalit H.","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Ndaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Hargrove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 E.","family":"Manautou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce T.","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeswari M.","family":"Kasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuling","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2016.03.006_bib0005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/ajh.2830360314","article-title":"Severe and fatal anthracycline cardiotoxicity at cumulative doses below 400mg\/m2: evidence for enhanced toxicity with multiagent chemotherapy","volume":"36","author":"Watts","year":"1991","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.phrs.2016.03.006_bib0010","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1056\/NEJM199809243391307","article-title":"Doxorubicin-Induced cardiomyopathy","volume":"339","author":"Singaland","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2016.03.006_bib0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cncr.10201","article-title":"Liposome-encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first-line therapy of metastatic breast carcinoma","volume":"94","author":"Harris","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.phrs.2016.03.006_bib0020","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/hon.827","article-title":"Liposome-encapsulated doxorubicin in combination with cyclophosphamide, vincristine, prednisone and rituximab in patients with lymphoma and concurrent cardiac diseases or pre-treated with anthracyclines","volume":"25","author":"Rigacci","year":"2007","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.phrs.2016.03.006_bib0025","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1023\/A:1008365716693","article-title":"Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500mg\/m2","volume":"11","author":"Safra","year":"2000","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.phrs.2016.03.006_bib0030","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000327767","article-title":"Palmar-Plantar erythrodysesthesia associated with chemotherapy and its treatment","volume":"4","author":"Farrand","year":"2011","journal-title":"Case Rep. Oncol."},{"key":"10.1016\/j.phrs.2016.03.006_bib0035","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/annonc\/mdl477","article-title":"Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia (\u2fffhand-foot\u2fff syndrome)","volume":"18","author":"Lorusso","year":"2007","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.phrs.2016.03.006_bib0040","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.tox.2005.07.023","article-title":"Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity","volume":"216","author":"Szebeni","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.phrs.2016.03.006_bib0045","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/1061186021000072447","article-title":"Dose dependency of pharmacokinetics and therapeutic efficacy of pegylated liposomal doxorubicin (DOXIL) in murine models","volume":"10","author":"Gabizon","year":"2002","journal-title":"J. Drug Target."},{"key":"10.1016\/j.phrs.2016.03.006_bib0050","first-page":"1409","article-title":"Outcomes analysis of an alternative formulation of PEGylated liposomal doxorubicin in recurrent epithelial ovarian carcinoma during the drug shortage era","volume":"7","author":"Berger","year":"2014","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.phrs.2016.03.006_bib0055","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v26.i2.20","article-title":"Role of block copolymer nanoconstructs in cancer therapy","volume":"26","author":"Upadhyay","year":"2009","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.phrs.2016.03.006_bib0060","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1039\/C4CS00329B","article-title":"Structure, function, self-assembly, and applications of bottlebrush copolymers","volume":"44","author":"Verduzco","year":"2015","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.phrs.2016.03.006_bib0065","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.biomaterials.2005.05.028","article-title":"Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: in vivo biodistribution and anti-tumor activity","volume":"27","author":"Hyung Park","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2016.03.006_bib0070","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.biomaterials.2013.11.022","article-title":"Hypoxia-responsive polymeric nanoparticles for tumor-targeted drug delivery","volume":"35","author":"Thambi","year":"2014","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.phrs.2016.03.006_bib0075","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1021\/acs.biomac.5b01311","article-title":"Doxorubicin-Loaded carborane-conjugated polymeric nanoparticles as delivery system for combination cancer therapy","volume":"16","author":"Xiong","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.phrs.2016.03.006_bib0080","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1021\/bm5013822","article-title":"Long circulating self-assembled nanoparticles from cholesterol-containing brush-like block copolymers for improved drug delivery to tumors","volume":"15","author":"Tran","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.phrs.2016.03.006_bib0085","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1002\/pola.23354","article-title":"Synthesis and characterization of side-chain liquid crystalline polymers bearing cholesterol mesogen","volume":"47","author":"Ahn","year":"2009","journal-title":"J. Polym. Sci. A: Polym. Chem."},{"key":"10.1016\/j.phrs.2016.03.006_bib0090","doi-asserted-by":"crossref","first-page":"8245","DOI":"10.1021\/ma401448j","article-title":"Interplay between liquid crystalline order and microphase segregation on the self-assembly of side-chain liquid crystalline brush block copolymers","volume":"46","author":"Deshmukh","year":"2013","journal-title":"Macromolecules"},{"key":"10.1016\/j.phrs.2016.03.006_bib0095","doi-asserted-by":"crossref","first-page":"7449","DOI":"10.1038\/ncomms8449","article-title":"A drug-specific nanocarrier design for efficient anticancer therapy","volume":"6","author":"Shi","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2016.03.006_bib0100","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF00434396","article-title":"Doxorubicin pharmacokinetics after intravenous and intraperitoneal administration in the nude mouse","volume":"5","author":"Johansen","year":"1981","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.phrs.2016.03.006_bib0105","doi-asserted-by":"crossref","first-page":"12030","DOI":"10.1021\/la302144r","article-title":"Carboxylesterase-triggered hydrolysis of nanoparticle PEGylating agents","volume":"28","author":"Howard","year":"2012","journal-title":"Langmuir: ACS J. Surf. Colloids"},{"key":"10.1016\/j.phrs.2016.03.006_bib0110","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1208\/s12248-009-9086-3","article-title":"Nanoparticles containing anti-inflammatory agents as chemotherapy adjuvants II: role of plasma esterases in drug release","volume":"11","author":"Lu","year":"2009","journal-title":"AAPS J."},{"key":"10.1016\/j.phrs.2016.03.006_bib0115","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.coph.2014.09.019","article-title":"Progress in the delivery of nanoparticle constructs: towards clinical translation","volume":"18","author":"Ryanand","year":"2014","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.phrs.2016.03.006_bib0120","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejpb.2015.03.018","article-title":"Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy","volume":"93","author":"Perez-Herreroand","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.phrs.2016.03.006_bib0125","series-title":"Poly(ethylene Glycol) Chemistry: Biotechnical and Biomedical Applications (Topics in Applied Chemistry)","author":"Harris","year":"1992"},{"key":"10.1016\/j.phrs.2016.03.006_bib0130","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1096\/fasebj.3.7.2469614","article-title":"Lipid regulation of cell membrane structure and function","volume":"3","author":"Yeagle","year":"1989","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2016.03.006_bib0135","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.biomaterials.2011.11.032","article-title":"The use of cholesterol-containing biodegradable block copolymers to exploit hydrophobic interactions for the delivery of anticancer drugs","volume":"33","author":"Lee","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2016.03.006_bib0140","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1021\/bm900345m","article-title":"Evaluation of polymeric micelles from brush polymer with poly(-caprolactone)-b-poly(ethylene glycol) side chains as drug carrier","volume":"10","author":"Du","year":"2009","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.phrs.2016.03.006_bib0145","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1021\/ja003305m","article-title":"Inhibition of cell adhesion to fibronectin by oligopeptide-substituted polynorbornenes","volume":"123","author":"Maynard","year":"2001","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.phrs.2016.03.006_bib0150","doi-asserted-by":"crossref","first-page":"15870","DOI":"10.1021\/ja045664d","article-title":"Tuning the hemolytic and antibacterial activities of amphiphilic polynorbornene derivatives","volume":"126","author":"Ilker","year":"2004","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.phrs.2016.03.006_bib0155","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1021\/bm201812u","article-title":"Impact of RGD nanopatterns grafted onto titanium on osteoblastic cell adhesion","volume":"13","author":"Nguyen","year":"2012","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.phrs.2016.03.006_bib0160","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/adhm.201300017","article-title":"Oil-filled lipid nanoparticles containing 2\u2ff2-(2-bromohexadecanoyl)-docetaxel for the treatment of breast cancer","volume":"2","author":"Feng","year":"2013","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.phrs.2016.03.006_bib0165","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jconrel.2009.10.014","article-title":"Size and shape effects in the biodistribution of intravascularly injected particles","volume":"141","author":"Decuzzi","year":"2010","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.phrs.2016.03.006_bib0170","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jconrel.2013.09.013","article-title":"Factors controlling the pharmacokinetics: biodistribution and intratumoral penetration of nanoparticles","volume":"172","author":"Ernsting","year":"2013","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.phrs.2016.03.006_bib0175","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1124\/pr.56.2.6","article-title":"Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity","volume":"56","author":"Minotti","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.phrs.2016.03.006_bib0180","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/jps.2600640939","article-title":"Reduction of doxorubicin (adriamycin) bone marrow toxicity","volume":"64","author":"Harris","year":"1975","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.phrs.2016.03.006_bib0185","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.nano.2009.02.002","article-title":"PEGylated PLGA nanoparticles for the improved delivery of doxorubicin","volume":"5","author":"Park","year":"2009","journal-title":"Nanomed.: Nanotechnol. Biol. Med."},{"key":"10.1016\/j.phrs.2016.03.006_bib0190","doi-asserted-by":"crossref","first-page":"640","DOI":"10.18632\/oncotarget.543","article-title":"A composite polymer nanoparticle overcomes multidrug resistance and ameliorates doxorubicin-associated cardiomyopathy","volume":"3","author":"Pramanik","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2016.03.006_bib0195","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1021\/mp500093c","article-title":"Synergistic nanoparticulate drug combination overcomes multidrug resistance increases efficacy and reduces cardiotoxicity in a nonimmunocompromised breast tumor model","volume":"11","author":"Shuhendler","year":"2014","journal-title":"Mol. Pharm."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816301803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816301803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T09:15:29Z","timestamp":1567674929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661816301803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":39,"alternative-id":["S1043661816301803"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2016.03.006","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced in vivo toxicity of doxorubicin by encapsulation in cholesterol-containing self-assembled nanoparticles","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2016.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}